MD239Y - Method of predicting the clinical development of I stage breast cancer - Google Patents
Method of predicting the clinical development of I stage breast cancer Download PDFInfo
- Publication number
- MD239Y MD239Y MDS20100028A MDS20100028A MD239Y MD 239 Y MD239 Y MD 239Y MD S20100028 A MDS20100028 A MD S20100028A MD S20100028 A MDS20100028 A MD S20100028A MD 239 Y MD239 Y MD 239Y
- Authority
- MD
- Moldova
- Prior art keywords
- predicting
- pathology
- mammary gland
- clinical evolution
- lgm
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 206010006187 Breast cancer Diseases 0.000 title 1
- 208000026310 Breast neoplasm Diseases 0.000 title 1
- 230000007170 pathology Effects 0.000 abstract 6
- 238000002512 chemotherapy Methods 0.000 abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 210000005075 mammary gland Anatomy 0.000 abstract 3
- 201000011510 cancer Diseases 0.000 abstract 2
- 208000027775 Bronchopulmonary disease Diseases 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000005907 cancer growth Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000002980 postoperative effect Effects 0.000 abstract 1
- 230000001850 reproductive effect Effects 0.000 abstract 1
- 231100000241 scar Toxicity 0.000 abstract 1
- 210000001685 thyroid gland Anatomy 0.000 abstract 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
Inventia se refera la medicina, in special la oncologie. Metoda de pronosticare a evolutiei clinice a cancerului glandei mamare stadiul I include relevarea urmatorilor indici: tipul de crestere a cancerului (TC), patologie a glandei tiroide (PGT), diametrul tumorii (DT), localizarea acesteia in glanda mamara (LGM), patologii bronhopulmonare (PBP), patologii ale organelor reproductive (POR), tipul tratamentului efectuat (TR), recidive in regiunea cicatricei postoperatorii (RC), patologie hepatica (PH), varsta pacientei (VP), aplicarea chimioterapiei (CT), dupa care, in baza valorilor acestor indici, se calculeaza functia discriminanta (F) conform formulei:F=2,395-2,867 x TC-1,823 x PGT-0,600 x DT+0,490 x LGM-1,221 x PBP-0,781 x POR+0.481 x TR-1,922 x RC-0,691 x PH+0,028 x VP-0,240 x CT,totodata, daca F>0, se pronosticheaza o evolutie clinica favorabila, iar daca F<0, se pronosticheaza o evolutie clinica nefavorabila a cancerului glandei mamare.The invention relates to medicine, in particular to oncology. The method for predicting the clinical evolution of stage I mammary gland cancer includes the following indices: type of cancer growth (CT), thyroid gland pathology (PGT), tumor diameter (DT), its location in the mammary gland (LGM), pathologies bronchopulmonary disease (PBP), pathology of the reproductive organs (ROP), type of treatment performed (TR), relapses in the postoperative scar region (RC), liver pathology (PH), age of the patient (VP), application of chemotherapy (CT), based on the values of these indices, the discriminant function (F) is calculated according to the formula: F = 2,395-2,867 x TC-1,823 x PGT-0,600 x DT + 0.490 x LGM-1,221 x PBP-0.781 x POR + 0.481 x TR-1,922 x RC-0.691 x PH + 0.028 x VP-0.240 x CT, at the same time, if F> 0, a favorable clinical evolution is predicted, and if F <0, an adverse clinical evolution of the mammary gland cancer is predicted.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20100028A MD239Z (en) | 2010-02-15 | 2010-02-15 | Method of predicting the clinical development of I stage breast cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20100028A MD239Z (en) | 2010-02-15 | 2010-02-15 | Method of predicting the clinical development of I stage breast cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD239Y true MD239Y (en) | 2010-07-30 |
| MD239Z MD239Z (en) | 2011-02-28 |
Family
ID=45815082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20100028A MD239Z (en) | 2010-02-15 | 2010-02-15 | Method of predicting the clinical development of I stage breast cancer |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD239Z (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2486518C1 (en) * | 2012-01-10 | 2013-06-27 | Учреждение Российской академии медицинских наук Научно-исследовательский институт онкологии Сибирского отделения Российской академии медицинских наук (НИИ онкологии СО РАМН) | Method for prediction of onset of local recurrences in surgical scars in unicentric invasive duct breast cancer in patients with preserved menstrual function |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD654Z (en) * | 2012-11-20 | 2014-02-28 | Валериу ПАЛАДЕ | Method for predicting the course of II and III stage malignant melanoma |
| MD726Z (en) * | 2013-07-23 | 2014-08-31 | Адриан КИШКА | Method for prognosticating the evolution of gastric precancerous states in men |
| RU2631940C1 (en) * | 2016-05-05 | 2017-09-28 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Means for breast cancer prediction |
-
2010
- 2010-02-15 MD MDS20100028A patent/MD239Z/en not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2486518C1 (en) * | 2012-01-10 | 2013-06-27 | Учреждение Российской академии медицинских наук Научно-исследовательский институт онкологии Сибирского отделения Российской академии медицинских наук (НИИ онкологии СО РАМН) | Method for prediction of onset of local recurrences in surgical scars in unicentric invasive duct breast cancer in patients with preserved menstrual function |
Also Published As
| Publication number | Publication date |
|---|---|
| MD239Z (en) | 2011-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hodgson | Late effects in the era of modern therapy for Hodgkin lymphoma | |
| Rajendran et al. | Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography imaging | |
| Baek et al. | Exploratory clinical trial of (4 S)-4-(3-[18F] fluoropropyl)-l-glutamate for imaging xC− transporter using positron emission tomography in patients with non–small cell lung or breast cancer | |
| Vaupel et al. | Blood flow and oxygenation status of prostate cancers | |
| Schuetz et al. | Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer | |
| MD239Y (en) | Method of predicting the clinical development of I stage breast cancer | |
| Klubo-Gwiezdzinska et al. | Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer | |
| Lee et al. | Soft tissue necrosis in head and neck cancer patients after transoral robotic surgery or wide excision with primary closure followed by radiation therapy | |
| Su et al. | The Value of 99mTc-PSMA SPECT/CT-Guided Surgery for Identifying and Locating Lymph Node Metastasis in Prostate Cancer Patients: H. Su et al. | |
| Rossi et al. | State of art and advances on the treatment of bone metastases from breast cancer: a concise review | |
| Zhao et al. | Maxillary pain is the first indication of the presence of multiple myeloma: a case report | |
| Decker et al. | Periodontal treatment in cancer patients: An interdisciplinary approach | |
| Ma et al. | Treatment de-intensification for HPV-associated oropharyngeal cancer: a definitive surgery paradigm | |
| Lotan | Promises and challenges of fluorescence cystoscopy | |
| Read et al. | PET-CT imaging in patients with chronic sternal wound infections prior to reconstructive surgery: A case series | |
| Vaz et al. | The current role of nuclear medicine in breast cancer | |
| Gardelle et al. | [76Br] Bromodeoxyuridine PET in tumor-bearing animals | |
| Yapp et al. | Non‐invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F‐EF5 and positron emission tomography | |
| Jung et al. | Post-treatment 18F-FDG PET/CT for predicting survival and recurrence in patients with advanced-stage head and neck cancer undergoing curative surgery | |
| Lyoubi et al. | Aggressive Mesenchymal chondrosarcoma of the maxilla: Case report | |
| Burr | Summary of ASBMR Task Force on ONJ | |
| Barbhuiya et al. | An updated review on the early detection and drug development targeting breast cancer | |
| Ngokwe et al. | Radiological characteristics of benign jaw tumours in Cameroon: 2010–2020 | |
| Elicin et al. | Impact of pretreatment second look 18FDG-PET/CT on stage and treatment changes in head and neck cancer | |
| Kur et al. | The diagnostic value of prostate-specific membrane antigen PET-CT in differentiating medication-related osteonecrosis of the jaw and metastasis to the jawbone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) |